RxDoctor Payments Data

Kyle Girod, MD

Orthopaedic Surgery of the Spine · Baton Rouge, LANPI 1740239003

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Spine Wave, Inc. at 53.2% of the total. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in LA, where the typical reported total is $12,239.

$6,238in general payments, 2019–2025

Across 108 payments — averaging $57.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spine Wave, Inc.$3K
  • Osseus Fusion Systems, LLC$889
  • Abbott$629
  • Boston Scientific$281
  • Ulrich Medical USA, Inc.$186
  • Seaspine Orthopedics Corporation$145
  • plus $793 from 10 others

What the payments were for

  • Food & beverage$6,17299%
  • Other$661%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,238 in reported general payments places this provider in the 35th percentile of 29 orthopaedic surgery of the spine providers in Louisiana.

See all orthopaedic surgery of the spine providers in Louisiana

Medicare billing

Part B allowed, 2024
$172,736
Medicare patients
344
Services billed
1,567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin185$1,537
Methylprednisolone237$1,380
Methocarbamol277$1,076
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen110$749
Diclofenac Sodium40$492
Meloxicam88$385
Tramadol Hcl127$362
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen33$268
Cephalexin12$214
Ketorolac Tromethamine11$161
Cyclobenzaprine Hcl66$143
Diclofenac Potassium14$138
Baclofen23$98
Ibuprofen15$96
Tizanidine Hcl24$88

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →